Heikki A Kuusanmäki

机构：University of Helsinki, Institute for Molecular Medicine Finland, Cancer Society of Finland · ORCID：0000-0002-1903-0408

发表论文 163 篇 · 总被引 2870 次 · h-index 21

代表论文

Predictors of response and rational combinations for the novel MCL ‐1 inhibitor MIK665 in acute myeloid leukemia (2025 · Molecular Oncology · 被引 4)
Drivers of clinical resistance to venetoclax and hypomethylating agents in acute myeloid leukemia and strategies for improving efficacy (2026 · HemaSphere · 被引 2)
Digital twin models for predicting venetoclax and azacitidine-induced neutropenia in patients with acute myeloid leukemia (2025 · npj Digital Medicine · 被引 2)
Supplementary Figure S5 from Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab–Auristatin Conjugate with a Wide Therapeutic Window (2026)
Supplementary Table S2 from Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab–Auristatin Conjugate with a Wide Therapeutic Window (2026)
Supplementary Figure S2 from Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab–Auristatin Conjugate with a Wide Therapeutic Window (2026)